Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers

• Sverre E. Kjeldsen,
• Krzysztof Narkiewicz,
• Michel Burnier,
• Suzanne Oparil

Affiliations

Sverre E. Kjeldsen

Departments of Cardiology and Nephrology, University of Oslo, Ullevaal Hospital

Krzysztof Narkiewicz

Department of Hypertension and Diabetology, Medical University of Gdansk

Michel Burnier

Service of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois

Suzanne Oparil

Vascular Biology and Hypertension Program, Department of Medicine, University of Alabama at Birmingham